CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 3, Randomized, Observer-Blind Study to Evaluate the Safety, Tolerability, Immunogenicity of Serum Institute of India's 10-Valent Pneumococcal Conjugate Vaccine (PNEUMOSIL®) Administered in a 2+1 Schedule to Healthy Infants in The Gambia

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03896477
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:42.409781+00:00
Published At: 2022-04-20T00:00:00+00:00
Record Updated At: 2022-04-20
Results Posted At: 2022-04-20
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Pneumonia, Pneumococcal"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2022-04-20"
protocolSection.identificationModule.nctId: "NCT03896477"
protocolSection.identificationModule.officialTitle: "A Phase 3, Randomized, Observer-Blind Study to Evaluate the Safety, Tolerability, Immunogenicity of Serum Institute of India\u0027s 10-Valent Pneumococcal Conjugate Vaccine (PNEUMOSIL\u00ae) Administered in a 2+1 Schedule to Healthy Infants in The Gambia"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2022-04-20"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.